Borsa Haberleri
Son finansal haberler · Güncellendi May 23, 2026
J.Jill Dördüncü Çeyrek Kazanç Çağrısı Özetleri
J.Jill Q4 Earnings Call Highlights
The panelists generally agree that J.Jill is facing severe challenges, including structural tariff headwinds, deteriorating margins, and weak sales. The …
FREYR Battery Dördüncü Çeyrek Kazanç Çağrısı Önemli Noktalar
FREYR Battery Q4 Earnings Call Highlights
The panel is largely bearish on T1 Energy, citing execution risks, funding gaps, and supply chain fragility. The company's pivot …
KOSPI Perşembe Günü Başka Bir Zıplamaya Hazır
KOSPI Due For Another Jump On Thursday
The panel generally agrees that the KOSPI's 8.44% bounce is a relief rally rather than a trend reversal, driven by …
Altın Kafes Altındaki Nükleer Enerji Hisse Senedi, Pasif Gelirinizi Aşırı Yükseltme Potansiyeline Sahip
The Under-the-Radar Nuclear Energy Stock That Could Supercharge Your Passive Income
PNW is a stable utility income play with a 3.69% yield, but its high debt-to-equity ratio, 71% payout ratio, and …
Dave & Buster's Hisse Bugün Neden Fırladı
Why Dave & Buster's Stock Surged Today
The panel is divided on PLAY's future prospects. While some see potential in menu upgrades and new attractions, others question …
Neden Eli Lilly Hissesi Bugün Piyasayı Geride Bıraktı
Why Eli Lilly Stock Trounced the Market Today
The panel is divided on Eli Lilly's Foundayo approval, with concerns about real-world efficacy, payer adoption, and operational execution outweighing …
Bu 3 Enerji Hissesi 2026'da S&P 500'ü Geride Bırakabilir
These 3 Energy Stocks May Outperform the S&P 500 in 2026
The panel's net takeaway is that the article's thesis of sustained high oil prices through 2026 due to Middle East …
Nvidia Hissesi 13 Yıl Sonra İlk Kez Bunu Yaptı. Tarih Sonra Neler Olabileceğini Gösteriyor.
Nvidia Stock Just Did This for the First Time in 13 Years. History Shows What May Happen Next.
The panel is divided on NVDA's valuation, with some seeing it as a value trap or a sign of an …
FDA Eli Lilly'nin Foundayo Kilo Verme İlacını Onayladı
FDA Approves Eli Lilly's Foundayo Weight-Loss Pill
Foundayo's success hinges on payer coverage and real-world tolerability, with potential for significant market expansion if these hurdles are overcome.
1 Yapay Zeka (AI) Yazılım Hissesi, Dan Ives'e Göre Uçmadan Önce Avuç Avuç Alınmalı
1 Artificial Intelligence (AI) Software Stock to Buy Hand Over Fist Before It Soars 62%, According to Dan Ives
Panelists debate the validity of Palantir's $230 price target, with some questioning the revenue stability and margins of government contracts, …
Bugünkü Borsa, 1 Nisan: Intel 14,2 Milyar Dolarlık Fabrika Geri Alımıyla Yükselişte
Stock Market Today, April 1: Intel Surges on $14.2 Billion Fab Buyback
Intel's $14.2B buyout of Apollo's Fab 34 stake signals confidence in its foundry roadmap and operational control, but raises concerns …
Abonelikleri İptal Etmeyi Kolaylaştıran Yeni Yasalar
New laws to make it easier to cancel subscriptions
The panel generally agrees that the UK's new subscription laws will introduce regulatory friction, particularly for subscription-based businesses like streaming …